Clinical Trial Update: Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy [NA]

View source ↗

Summary

This clinical trial update reports bone mineral density changes in adults with hyperphenylalaninemia treated with Kuvan. The study (NCT01541397) was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphenylalaninemia
• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Hyperphenylalaninemia, Phenylketonuria | NA | Status: TERMINATED | Results posted: 2015-07-07